Background illustration for clinical trials search

Paid Clinical Trials Renton

Discover 1,436 paid clinical trials in Renton, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA)

for
Leiomyosarcoma
Location: Seattle WA, Santa Monica CA, Phoenix AZ, Rochester MN,
Sponsor: Philogen S.p.A.

Sex: All

Age: 16 - 70+

Code: NCT03420014

Phase2, Recruiting

Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

for
EPP, XLP
Location: Seattle WA
Sponsor: Tanabe Pharma America, Inc.

Sex: All

Age: 12 - 70+

Code: NCT05005975

Phase3, Recruiting

Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy

for
Pediatric Patients Treated With Radiation Therapy
Location: Seattle WA, San Francisco CA, Salt Lake City UT,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 0 - 21

Code: NCT01696721

Recruiting

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

for
Myelodysplastic Syndromes, Acute Myeloid Leukemia,
Location: Seattle WA, Portland OR, Salem OR, Los Angeles CA,
Sponsor: Taiho Oncology, Inc.

Sex: All

Age: 18+

Code: NCT04256317

Phase2, Phase3, Recruiting

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

for
Metastatic Non Small Cell Lung Cancer
Location: Seattle WA, Portland OR, Gilbert AZ, Fargo ND,
Sponsor: Iovance Biotherapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT04614103

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Prostatic Neoplasms, Castration-Resistant
Location: Seattle WA, Victoria, Vancouver, Springfield OR,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07225946

Phase3, Recruiting

CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin

for
Sarcoma
Location: Seattle WA, Santa Monica CA, Pittsburgh PA,
Sponsor: CBA Research

Sex: All

Age: 18+

Code: NCT03002805

Phase1, Recruiting

A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS

for
AML, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia,
Location: Seattle WA, Denver CO, Gilbert AZ, Dallas TX, Tyler TX,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT04358393

Phase1, Phase2, Recruiting

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

for
Follicular Lymphoma, Marginal Zone Lymphoma
Location: Seattle WA, Rochester MN, Rochester NY, Boston MA
Sponsor: Enterome

Sex: All

Age: 18+

Code: NCT04669171

Phase1, Phase2, Recruiting

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

for
Mucositis, Nephrotoxicity, Ototoxicity
Location: Seattle WA, Merced CA, Santa Maria CA, La Jolla CA,
Sponsor: Matrix Biomed, Inc.

Sex: All

Age: 18+

Code: NCT03480971

Phase2, Recruiting
New

OM336 in Autoimmune Cytopenias

for
AIHA - Warm Autoimmune Hemolytic Anemia,
Location: Seattle WA, Duarte CA, Ann Arbor MI, Washington D.C. DC
Sponsor: Lakefront Biotherapeutics West LLC

Sex: All

Age: 18 - 70+

Code: NCT07083960

Phase1, Recruiting
New

SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer

for
Advanced Lung Non-Small Cell Carcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT07322341

Phase2, Recruiting

Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma

for
Ann Arbor Stage II Follicular Lymphoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06442475

Phase2, Recruiting

Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC

for
Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer,
Location: Seattle WA, Milwaukee WI
Sponsor: Pancreatic Cancer Research Team

Sex: All

Age: 18+

Code: NCT03634332

Phase2, Recruiting

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

for
Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer,
Location: Seattle WA, Salt Lake City UT, Santa Monica CA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06586515

Phase1, Recruiting

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

for
Non Small Cell Lung Cancer, Lung Cancer, Breast Cancer,
Location: Seattle WA, Beverly Hills CA, Duarte CA,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT05983432

Phase1, Recruiting

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

for
Neuroendocrine Tumors Unresectable,
Location: Seattle WA, Omaha NE, Rochester MN, Iowa City IA,
Sponsor: Perspective Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT05636618

Phase1, Phase2, Recruiting

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Prostate Cancer
Location: Seattle WA, San Francisco CA, Murray UT, Duarte CA,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT04221542

Phase1, Recruiting

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

for
Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia,
Location: Seattle WA, Houston TX, Cincinnati OH, Nashville TN,
Sponsor: Vincerx Pharma, Inc.

Sex: All

Age: 18+

Code: NCT06034275

Phase1, Recruiting

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

for
Solid Tumor, Adult, Metastatic Breast Cancer,
Location: Seattle WA, San Francisco CA, Los Angeles CA, Duarte CA,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06625775

Phase1, Recruiting